ReShape Lifesciences Inc. announced that Scott P. Youngstrom, Senior Vice President, Finance and Chief Financial Officer provided the Company with notice of his resignation on August 1, 2019, effective October 1, 2019.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.183 USD | -2.66% | -1.19% | -26.71% |
05-15 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.71% | 4.41M | |
+7.76% | 223B | |
+11.61% | 195B | |
+18.84% | 144B | |
+30.01% | 111B | |
+2.32% | 65.19B | |
+13.85% | 53.02B | |
+2.68% | 50.28B | |
+6.76% | 44.15B | |
+1.80% | 36.45B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- ReShape Lifesciences Inc. Announces Resignation of Scott P. Youngstrom as Senior Vice President, Finance and Chief Financial Officer, Effective October 1, 2019